InflaRx NV (IFRX) - Sotuvning sof marjinal rentabelligi

inflarx.de (IFRX) - korporativ logo

Immunoterapiya ishlanmalarining sikllikka bog'liq bo'lmagan tabiati va AQSh distribyutorlari bilan yaqin hamkorlik InflaRx N.V. (IFRX) barqarorligini ta'minlaydi. Sotuvlarning sof daromadlilik profili biznesning qarz mablag'lari xarajatlariga moslashganini ko'rsatadi va qiymat 0.00 darajasida barqarorlashgan. Germaniyaning ushbu biotexnologiya firmasi intensiv terapiya bo'limlaridagi og'ir yallig'lanishga qarshi kurashish uchun C5a ingibitorlarini ishlab chiqmoqda va pyoderma gangrenosum terapiyasini maqsad qilgan.

inflarx.de (IFRX) Sof marja: 04.07.2022 - 19.11.2026 davri uchun

InflaRx NV (IFRX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi ko'rsatkichlari:
Kompaniyaning jamlanma tahlili:inflarx.de, IFRX
InflaRx ishlab chiqargan mahsulot

Tebranishlar davrida kapitalni himoya qilish uchun biznesning har bir dollar daromaddan sof foyda olish qobiliyatini baholash juda muhimdir. Ushbu koeffitsiyent barcha operatsion va soliq majburiyatlari qoplanganidan keyin qolgan mablag'larni o'lchaydi. InflaRx N.V. (IFRX) kompaniyasining tijorat foyda marjasini tahlil qilish orqali investor marjalar xarajatlar inflyatsiyasiga qanchalik tez moslashishini aniqlashi mumkin. InflaRx N.V. (IFRX) uchun bu davlat protokollari uchun sog'liqni saqlash gigantlari bilan kurashda omon qolish ko'rsatkichi bo'lib xizmat qiladi. Trend chizig'idagi keskin tebranishlar universal immunoblokatorlarga nisbatan raqobatlashish qobiliyatini yo'qotish xavfidan signal beradi.

InflaRx N.V. kimlar bilan raqobatlashadi

argenx (ARGX) - Sof marja|BNTX - Kompaniya sotuv marjasi|ABVX (Abivax Pharma) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi ADMA Bio (ADMA)|Sof foyda bo'yicha sotuv rentabelligi PTGX (Protagonist Therapeutics Inc)|Sotuvning sof marjinal rentabelligi immunovant.com (IMVT)|Sof marja kiniksa.com KNSA|Grifols SA (GRFS) - Sof marja|Adaptive Biotechnologies Inc. - Sotuvning sof marjinal rentabelligi|Sof marja Celldex Therapeutics|AUPH: Sotuvning sof marjinal rentabelligi|BCRX - Kompaniya sotuv marjasi|VERA (Vera Corp) - Sotuvning sof marjinal rentabelligi|Dianthus Pharma (DNTH) - Kompaniya sotuv marjasi|Sof marja Pharvaris Pharma (PHVS)|Sotuvning sof marjinal rentabelligi AbCellera Corp (ABCL)|Sotuvning sof marjinal rentabelligi TRML (Tourmaline Bio Inc)|Kompaniya sotuv marjasi precigen.com (PGEN)|PHAR - Sof marja|Sof foyda normasi NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Sof foyda bo'yicha sotuv rentabelligi|Zenas Corp (ZBIO) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi IMNM|GOSS: Sof foyda normasi|Sof marja KalVista Pharma (KALV)|SEPN - Sof marja|Sotuvning sof marjinal rentabelligi PVLA (pieris.com)|Sotuvning sof marjinal rentabelligi Savara Pharma SVRA|RIGL: Sof foyda bo'yicha sotuv rentabelligi|ANAB - Sotuvning sof marjinal rentabelligi|ATXS: Sotuvning sof marjinal rentabelligi|ENGN - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi RAPT|JBIO (Aerovate Therapeutics Inc) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi ACRS|Sof foyda bo'yicha sotuv rentabelligi kyvernatx.com KYTX|Sotuvning sof marjinal rentabelligi TLSA (Tiziana Life Sciences, Ltd.)|Sotuvning sof marjinal rentabelligi Cabaletta Bio CABA|VTYX: Sof foyda bo'yicha sotuv rentabelligi|Theratechnologies Inc. (THTX) - Sof foyda bo'yicha sotuv rentabelligi|AVTX: Sotuvning sof marjinal rentabelligi|ELDN - Kompaniya sotuv marjasi|AGEN (Agenus, Inc) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi Climb Bio, Inc.|Sof marja Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi ADAG (Adagene Inc)|IMA - Sof foyda bo'yicha sotuv rentabelligi|STTK - Sof marja|EQ (equilliumbio.com) - Sotuvning sof rentabelligi|CNTB: Sotuvning sof marjinal rentabelligi|Immunic Inc (IMUX) - Sotuvning sof marjinal rentabelligi|ATRA (Atara Biotherapeutics Inc) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi x4pharma.com (XFOR)|Sotuvning sof marjinal rentabelligi ACET|Sof foyda bo'yicha sotuv rentabelligi Celularity Corp CELU|INmune Bio Inc - Sof foyda bo'yicha sotuv rentabelligi|BRNS (Barinthus Bio) - Sof foyda marjasi|KZR - Sof marja|Kompaniya sotuv marjasi sabbiotherapeutics.com SABS|Akari Therapeutics PLC (AKTX) - Sof marja|ENLV - Kompaniya sotuv marjasi|QTTB (Q32 Bio) - Sotuvning sof marjinal rentabelligi|Sof marja GeoVax Labs Inc GOVX|Sof marja Edesa Biotech (EDSA)|Sof foyda bo'yicha sotuv rentabelligi iBio IBIO|Carisma Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|XTLB - Sof foyda bo'yicha sotuv rentabelligi|BOLT - Sof marja|Sof foyda normasi HCWB (hcwbiologics.com)|APVO: Sotuvning sof marjinal rentabelligi|aimimmuno.com (AIM) - Sotuvning sof marjinal rentabelligi|Sof marja aditxt.com|Sof foyda bo'yicha sotuv rentabelligi GRI Bio Corp (GRI)|Sof marja XORTX Therapeutics Inc. (XRTX)|Sof foyda bo'yicha sotuv rentabelligi ReShape Lifesciences HIND|Sof marja Revelation Biosciences REVB|INDP: Sotuvning sof rentabelligi|SCNI - Sof marja|CALI (calcimedica.com) - Sotuvning sof rentabelligi|AFMD (Affimed Therapeutics) - Sof foyda bo'yicha sotuv rentabelligi|Allakos Therapeutics (ALLK) - Sotuvning sof marjinal rentabelligi|HOOK (HOOKIPA) - Sotuvning sof marjinal rentabelligi|igmbio.com (IGMS) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi ITOS|OCEA (Ocean Biomedical) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi TCBP (TC BioPharm (Holdings) PLC)|THRD - Sof foyda bo'yicha sotuv rentabelligi